Advanced Biotechnologies Inc

Advanced Biotechnologies Inc (ABI) is recognized as The Virology Resource Centre™. ABI specializes in the development and manufacturing of products for the research diagnosis, monitoring, and treatment of infectious diseases.

ABI's expertise are HIV, HTLV, HSV, VZV, EBV, CMV, HHV-6, HHV-7, HHV-8, RSV, SIV, Rubella, Influenza, Vaccinia, Chlamydia, Neisseria and Toxoplasma.

Arbor Assays

Arbor Assays' company philosophy is to build the highest quality detection and immunoassay products for clinically important biomolecules. Their primary customer focus is both pharmaceutical and clinical scientists. Arbor Assays builds robust immunoassay and enzyme activity kits to quantitate biomolecules in biological matrices, and finds delight in taking on the most technically challenging assays there are to develop.

Arbor Assays' products fall into three general areas:

• Immunoassay Kits

These are unique kits for the detection of biological and chemical molecules. This broad group of products includes immunoassays for the detection of both large and small molecules.

• Detection Kits

These unique products quantitatively detect the activity of an enzymatic reaction or the amount of a particular chemical or biochemical in a sample. See our list of products.

• Contract & Consulting Services

The scientists at Arbor Assays have developed a number of custom products for other companies and Universities. Arbor Assays also offers consultation services on chemistry options for the generation of specific antibodies, kit product development and general detection technology.

Biocolor

Biocolor produces high quality, validated bioanalytical assays, which allow rapid and accurate detection and quantification of numerous chemicals and cell states in mammalian cells, tissues and fluids.

Their products include Apoptosis, Collagen, Glycosaminoglycans and Elastin Assay Kits.

BioPorto Diagnostics

BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector.

The Company’s developments include a test (NGAL) to diagnose and monitor acute kidney damage. BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases.

BioPorto Diagnostics A/S offers the range of antibodies under the AntibodyShop® brand. Focus areas include:

• Bioactive peptides
• Complement system and collectins
• Cell biology

Home Page: http://www.bioporto.com and http://www.antibodyshop.com

Glycosan Biosystems

Glycosan BioSystems manufactures ExtracelTM and HyStemTM lines of biocompatible, optimizable hydrogel matrices for general 3-D and stem cell culture. The foundation for both lines is thiol-modified hyaluronic acid which allows a variety of thiol-modified proteins, peptides, or small molecules to be easily crosslinked into the hydrogel. The Extracel line is specifically designed for general and 3-D cell culture. The HyStem line is designed for stem cell culture and transplantation, providing the bridge between cell culture and cell therapy.

J R Scientific

J R Scientific is a pioneer in the manufacture of classical and custom cell culture media and sera products on a direct basis and under special OEM contracts with other suppliers. J R Scientific, Inc. was the first to provide the industry with large-scale powdered media, low protein serum-free hybridoma and insect cell culture media, and bulk liquid media transfer systems.

Zen-Bio

Zen-Bio, Inc. (ZB) is a leading provider of research tools for the study of human metabolic disease. The company, founded in 1995, performs contract research for major pharmaceutical and biotechnology companies around the world.

The company pioneered tissue engineering with adult adipose-derived stem cells and is currently researching the role obesity plays in the development and on-set of metabolic disease.

ZB's mission is to provide the highest quality cell, reagents and contract services to the biomedical research community; to develop and commercialize research tools and to leverage our expertise in this field into successful treatments for metabolic diseases through research and development strategic alliances.

ZytoVision

Modern medical research has lead to a continuous growth in understanding of pathological aberrations. This understanding is the basis of the development of innovative diagnostic products with prognostic, predicative and therapeutic value by ZytoVision®.

ZytoLight ® products for Fluorescence in situ Hybridization (FISH) are designed for the identification of genetic aberrations e.g. translocations, deletions, amplifications, and chromosomal aneuploidies associated with tumors and genetic diseases.

ZytoDot ® products for Chromogenic in situ Hybridization (CISH) are designed for the detection of aneuploidies and gene amplifications associated with tumors and genetic diseases using an IHC-like procedure and light microscopy. ZytoFast ® products for Chromogenic in situ Hybridization (CISH) are designed for the detection and discrimination of human pathogen viruses e.g. HPV, EBV, CMV and the determination of lymphocyte clonality by detecting Ig-κ and Ig-λ light chain RNA.